The IBC International Conference - Virtual Education Day, hosted by the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic and MD Anderson Cancer Center, is scheduled for December 5, 2020. The virtual education session is free.
Abstracts may be submitted for the Poster Session, and must be received no later than Friday, November 13, 2020. Submit to IBC2020@mdanderson.org
GOAL
Inflammatory breast cancer (IBC) is a highly aggressive breast cancer, with a very poor prognosis relative to other breast cancers due to its strong potential to metastasize, relapse, and possibly result in patient death. There have been multiple attempts to develop efficacious targeted therapy for this disease. Unfortunately, the federal government (FDA) has not approved any IBCspecific drugs or diagnostic tools yet. Therefore, there remains an urgent need to understand mechanistically how to induce a therapeutic effect that can prolong the survival of patients with IBC. This two-day meeting is targeted for clinical investigators, practicing physicians, basic researchers, patient advocates and institutions aiming to pioneer IBC clinics in their geographic regions, to enhance their knowledge and to facilitate collaboration to accelerate clinical therapy and research trial development, beneficial for patients with IBC. We expect new ideas and collaborations from this meeting to lead to improvement of disease outcome, such as survival or tumor response, over the next 3 years.